相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Drug resistance related to aberrant glycosylation in colorectal cancer
Ninon Very et al.
ONCOTARGET (2018)
Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling
Ines Gomes Ferreira et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Glycans as Regulatory Elements of the Insulin/IGF System: Impact in Cancer Progression
Julio Cesar M. de-Freitas-Junior et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors
Patricia M. LoRusso et al.
INVESTIGATIONAL NEW DRUGS (2017)
Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis
Jun-Feng Chen et al.
ONCOLOGY REPORTS (2017)
RON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis
Kelsi Andrade et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Splice variants of the extracellular region of RON receptor tyrosine kinase in lung cancer cell lines identified by PCR and sequencing
Soundararajan Krishnaswamy et al.
BMC CANCER (2017)
Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer
Stefan Mereiter et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
Influence of immunoglobulin isotype on therapeutic antibody function
Stephen A. Beers et al.
BLOOD (2016)
Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma
Wan-Ling Ho et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics
Jeffery Chakedis et al.
ONCOTARGET (2016)
RON kinase isoforms demonstrate variable cell motility in normal cells
Alissa Greenbaum et al.
HELIYON (2016)
N-Glycosylation as determinant of epidermal growth factor receptor conformation in membranes
Karol Kaszuba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
FGFR3 Transmembrane Domain Interactions Persist in the Presence of Its Extracellular Domain
Sarvenaz Sarabipour et al.
BIOPHYSICAL JOURNAL (2013)
Expression of ST3GAL4 Leads to SLex Expression and Induces c-Met Activation and an Invasive Phenotype in Gastric Carcinoma Cells
Catarina Gomes et al.
PLOS ONE (2013)
Ron Knockdown and Ron Monoclonal Antibody IMC-RON8 Sensitize Pancreatic Cancer to Histone Deacetylase Inhibitors (HDACi)
Yi Zou et al.
PLOS ONE (2013)
Anti-c-Met antibodies recognising a temperature sensitive epitope, inhibit cell growth
Julin S. Wong et al.
ONCOTARGET (2013)
Rational Optimization of Conformational Effects Induced By Hydrocarbon Staples in Peptides and their Binding Interfaces
Dilraj Lama et al.
SCIENTIFIC REPORTS (2013)
Structure-based Comparative Analysis and Prediction of N-linked Glycosylation Sites in Evolutionarily Distant Eukaryotes
Phuc Vinh Nguyen Lam et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2013)
MSP-RON signalling in cancer: pathogenesis and therapeutic potential
Hang-Ping Yao et al.
NATURE REVIEWS CANCER (2013)
Specific and Nonspecific Effects of Glycosylation
Christopher R. Ellis et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Crystal Structure of the Sema-PSI Extracellular Domain of Human RON Receptor Tyrosine Kinase
Kinlin L. Chao et al.
PLOS ONE (2012)
Pros and cons of using aberrant glycosylation as companion biomarkers for therapeutics in cancer
Jeong-Gu Kang et al.
BMB REPORTS (2011)
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma
Daniel V. T. Catenacci et al.
CANCER BIOLOGY & THERAPY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells
Hang-Ping Yao et al.
MOLECULAR CANCER (2011)
Protein Characterization of a Candidate Mechanism SNP for Crohn's Disease: The Macrophage Stimulating Protein R689C Substitution
Natalia Gorlatova et al.
PLOS ONE (2011)
Tumour-associated carbohydrate antigens in breast cancer
Aurelie Cazet et al.
BREAST CANCER RESEARCH (2010)
From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer
Isabelle Dussault et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2009)
The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis
Sara E. Meyer et al.
DEVELOPMENTAL BIOLOGY (2009)
Altered expression of the RON receptor tyrosine kinase in various epithelial cancers and its contribution to tumourigenic phenotypes in thyroid cancer cells
M-H Wang et al.
JOURNAL OF PATHOLOGY (2007)
Agonistic monoclonal antibodies potentiate tumorigenic and invasive activities of splicing variant of the RON receptor tyrosine kinase
Hang-Ping Yao et al.
CANCER BIOLOGY & THERAPY (2006)
Protein glycosylation: New challenges and opportunities
CH Wong
JOURNAL OF ORGANIC CHEMISTRY (2005)
Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-γ and lipopolysaccharide
AC Morrison et al.
JOURNAL OF IMMUNOLOGY (2004)
The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation
D Angeloni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor
TG Johns et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Never say never again: protein glycosylation in pathogenic bacteria
I Benz et al.
MOLECULAR MICROBIOLOGY (2002)
分享论文
